Horizons Global Solutions LLC

Horizons Global Solutions LLC filed a Q4 amendment for Recce Pharmaceuticals on February 10, 2026.

Lobbying for Recce Pharmaceuticals · Pharmaceutical company focusing on synthetic anti-infectives.

As filed: HORIZONS GLOBAL SOLUTIONS LLC for RECCE PHARMACEUTICALS.

All filings by Horizons Global Solutions LLC · Everything Recce Pharmaceuticals has reported

Amended

The filer submitted a later report covering this same period, so the amounts here have been replaced. Site totals count only the latest version. See the current filing, posted Feb 10, 2026.

Filing · LD-2 quarterly report Q4 amendment

Reporting period

4th Quarter 2025

Oct 1 - Dec 31 · Posted Feb 10, 2026

Money reported

None

Registrations and no-activity reports carry no figure.

Official filing document

Lobbyists on this filing 2

JULIE LASSETER

Previously held: Former Congressional Aide (U.S. House, U.S. Senate), Former Schedule C (DOD)
STEPHEN ELLIOTT BOYD

Previously held: Assistant Attorney General at Department of Justice; former Congressional Aide (House and Senate)

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 1

HOUSE OF REPRESENTATIVES

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Health Issues

Development of anti-infectives for use responding to military burns.

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.